- Filed
- Jul 22, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2020 · Jul 1, 2021 | 141.78M sh |
| Cash And Equivalents | Q1 2020 · Mar 31, 2020 | $3.66M |
| Cash And Equivalents | Q1 2020 · Dec 31, 2019 | $4.45M |
| Current Liabilities | Q1 2020 · Mar 31, 2020 | $58.95M |
| Current Liabilities | Q1 2020 · Dec 31, 2019 | $54.73M |
| Total Liabilities | Q1 2020 · Mar 31, 2020 | $59.84M |
| Total Liabilities | Q1 2020 · Dec 31, 2019 | $55.59M |
| Current Assets | Q1 2020 · Mar 31, 2020 | $19.24M |
| Current Assets | Q1 2020 · Dec 31, 2019 | $19.17M |
| Total Assets | Q1 2020 · Mar 31, 2020 | $51.9M |
| Total Assets | Q1 2020 · Dec 31, 2019 | $54.03M |
| Stockholders Equity | Q1 2020 · Dec 31, 2019 | −$1.56M |
| Stockholders Equity restated | Q1 2020 · Mar 31, 2019 | $149.06M |
| Net Income | Q1 2020 · Dec 31, 2019 | −$222.3M |
| Net Income restated | Q1 2020 · Mar 31, 2019 | −$15.83M |
| Shares Diluted | Q1 2020 · Mar 31, 2019 | 103.57M sh |
| Capex | Q1 2020 · Mar 31, 2019 | $1.4M |
| Operating Cash Flow restated | Q1 2020 · Mar 31, 2019 | −$4.72M |
| Eps Diluted restated | Q1 2020 · Mar 31, 2019 | −$0.15 |
| Eps Basic restated | Q1 2020 · Mar 31, 2019 | −$0.15 |
| Rd Expense restated | Q1 2020 · Mar 31, 2019 | $2.55M |
| Operating Income restated | Q1 2020 · Mar 31, 2019 | −$14.39M |
| Revenue | Q1 2020 · Mar 31, 2019 | $13.07M |